FDA Approves First Cell Therapy for Type 1 Diabetes in the US

A woman with diabetes gives herself an insulin injection. ShutterStock

The first cellular therapy for type 1 diabetes, called Lantidra, was approved by the Food and Drug Administration (FDA) for use in the United States.

This is potentially good news for the 1.9 million people in the United States living with type 1 diabetes.